Beyond therapeutics, monoclonal antibodies shown to be effective in the clinic can help to facilitate laboratory research. Researchers use mAbs, also known as biosimilars, as tools to research novel therapies and uncover effective off-target applications. With known and approved data on toxicity and efficacy, researchers use these biologics as benchmarks in their studies, allowing them to accelerate their findings from bench to clinic.
ProSci offers more than 800 research-grade biosimilar antibodies in the following research areas: cancer, pain, blood-related diseases, bacterial infection, neurodegenerative, asthma, psoriasis and other dermatitis, rheumatoid arthritis and osteoporosis, inflammatory diseases, Crohn’s disease, virus infection, and diabetes and other autoimmune diseases.
Phone: 02 9698 2022
Selleck Chemicals FDA-approved Anticancer Drug Library
Selleck Chemicals (SelleckChem) offers a collection of 1734 approved drugs with potential...
Cytek Tonbo Mouse TBNK/Myeloid/Treg Kit
The kit has been designed to enable researchers to quickly perform basic immunophenotyping and...
FUJIFILM Irvine Scientific Shenandoah Cytokines
FUJIFILM Irvine Scientific provides recombinant cytokines to the academic and industrial...
